McNeil Dreams Of Tylenol PM Sleep-Aid Indication
This article was originally published in The Tan Sheet
Executive Summary
McNeil Consumer Healthcare says recent clinical data support a sleep-aid/pain relief indication for the ingredient combination in Tylenol PM
You may also be interested in...
New Products In Brief
Unisom extension targets nighttime pain: Sanofi-Aventis introduces the first dual-ingredient stock-keeping unit in the Unisom sleep-aid line, pairing diphenhydramine 50 mg with acetaminophen 325 mg in Unisom PM Pain SleepCaps. The product sells at $8.99 for 30 caplets. Unisom PM Pain's indication says it helps "relieve occasional sleeplessness when accompanied by a headache or other minor aches and pains," according to its website. Johnson & Johnson/McNeil is seeking FDA approval of a more explicit sleep-aid/pain relief indication for its similar Tylenol PM (diphenhydramine 25 mg/acetaminophen 500 mg) (1"The Tan Sheet" Aug. 23, 2010)
New Products In Brief
Unisom extension targets nighttime pain: Sanofi-Aventis introduces the first dual-ingredient stock-keeping unit in the Unisom sleep-aid line, pairing diphenhydramine 50 mg with acetaminophen 325 mg in Unisom PM Pain SleepCaps. The product sells at $8.99 for 30 caplets. Unisom PM Pain's indication says it helps "relieve occasional sleeplessness when accompanied by a headache or other minor aches and pains," according to its website. Johnson & Johnson/McNeil is seeking FDA approval of a more explicit sleep-aid/pain relief indication for its similar Tylenol PM (diphenhydramine 25 mg/acetaminophen 500 mg) (1"The Tan Sheet" Aug. 23, 2010)
J&J Expands Contaminated Packaging Recalls, Stoking House Investigation
Johnson & Johnson's ongoing quality control drama plays on with a follow-up recall of OTCs in potentially contaminated packaging